Stereoselectivity in drug metabolism and action: Effects of enzyme inhibition and induction

Therapeutic Drug Monitoring

Volumn 18, Issue 4, 1996, Pages 388-392

  Kroemer, Heyo K ^a   Fromm, Martin F ^a   Eichelbaum, Michel ^a  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

Drug metabolism; Induction; Inhibition; Stereoselectivity

Indexed keywords

CIMETIDINE; CYTOCHROME P450; HEXOBARBITAL; MEPHENYTOIN; PROPAFENONE; RIFAMPICIN; SULFINPYRAZONE; VERAPAMIL; WARFARIN;

CONFERENCE PAPER; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG CONFORMATION; DRUG DISPOSITION; DRUG EFFECT; DRUG ELIMINATION; DRUG EXCRETION; DRUG MONITORING; DRUG PROTEIN BINDING; ENZYME INDUCTION; HUMAN; INHIBITION KINETICS; PRIORITY JOURNAL; STEREOCHEMISTRY;

DRUG INTERACTIONS; ENZYME INDUCTION; ENZYME INHIBITORS; HUMANS; LIVER; MOLECULAR CONFORMATION; PHARMACEUTICAL PREPARATIONS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029832456     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199608000-00013     Document Type: Conference Paper

References (18)

1. Ariens EJ. Nonchiral, homochiral and composite chiral drugs. Trends Pharmacol Sci 1993;14:68-75.
2. Zhou HH, Anthony LB, Wood AJJ, Wilkinson GR. Induction of polymorphic 4′-hydroxylation of S-mephenytoin by rifampicin. Br J Clin Pharmacol 1990;30:471-5.
3. Smith DA, Chandler MHH, Shedlofsky SI, Wedlund PJ, Blouin RA. Age-dependent stereoselective increase in the oral clearance of hexobarbitone isomers caused by rifampicin. Br J Clin Pharmacol 1991;32:735-9.
4. Relling MV, Aoyama T, Gonzalez FJ, Meyer UA. Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily. J Pharmacol Exp Ther 1990;252:442-7.
5. Seideman P, Ericsson Ö, Gröningsson K, von Bahr C. Effect of pentobarbital on the formation of diastereomeric oxazepam glucuronides in man: analysis by high performance liquid chromatography. Acta Pharmacol Toxicol Copenh 1981; 49:200-4.
6. Smith MS, Benyunes MC, Björnson TD, Shand DG, Pritchett ELC. Influence of cimetidine on verapamil kinetics and dynamics. Clin Pharmacol Ther 1984;36:551-4.
7. Loi CM, Rollins DE, Dukes GE, Peat MA. Effect of cimetidine on verapamil disposition. Clin Pharmacol Ther 1985; 37:654-7.
8. Abernethy DR, Schwartz JB, Todd EL. Lack of interaction between verapamil and cimetidine. Clin Pharmacol Ther 1985;38:342-9.
9. Wing LMH, Miners JO, Lillywhite KJ. Verapamil disposition - effects of sulphinpyrazone and cimetidine. Br J Clin Pharmacol 1985;19:385-91.
10. Mikus G, Eichelbaum M, Fischer C, Gumulka S, Klotz U, Kroemer HK. Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action. J Pharmacol Exp Ther 1990;253:1042-8.
11. Somogyi A, Muirhead M. Pharmacokinetic interactions of cimetidine 1987. Clin Pharmacokinet 1987;12:321-66.
12. Rettie AE, Korzekwa KR, Kunze KL, et al. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. Chem Res Toxicol 1992;5:54-9.
13. Toon S, Hopkins KJ, Garstang FM, Rowland M. Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man. Eur J Clin Pharmacol 1987;32:165-72.
14. Toon S, Low LK, Gibaldi M, et al. The warfarin-sulfinpyrazone interaction: stereochemical considerations. Clin Pharmacol Ther 1986;39:15-24.
15. Kroemer HK, Fischer C, Meese CO, Eichelbaum M. Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism. Mol Pharmacol 1991;40: 135-42.
16. Kroemer HK, Funck-Brentano C, Silberstein DJ, et al. Stereoselective disposition and pharmacologic activity of propafenone enantiomers. Circulation 1989;79:1068-76.
17. Kroemer HK, Fromm MF, Bühl K, Terefe H, Blaschke G, Eichelbaum M. An enantiomer-enantiomer interaction of (S)-and (R)-propafenone modifies the effect of racemic drug therapy. Circulation 1994;89:2396-400.
18. Roden DM. Mirror, mirror on the wall... Stereochemistry in therapeutics. Circulation 1994;89:2451-3.